Come along to a free information event on 15 February to learn about breast surgery, body reshaping and abdominoplasty
Some of the principal treatments carried out by Dr Zaheer Yousef at Spire include:
I am the clinical lead for heart failure, cardiomyopathies, and heart failure devices (biventricular pacemakers and defibrillators) at the University Hospital of Wales.
I've implanted over 1,000 heart failure devices and am a European Society of Cardiology proctor for these procedures. I lead an active research group and serve as the UK Chief investigator of several International clinical trials. I was also appointed as a National Institute of Social Care and Health Research (NISCHR) fellow in 2011.
I have published more than 50 high impact medical papers and contributed to several chapters in medical textbooks.
I'm currently approved by the Football Association for cardiac screening of elite athletes.
|Telephone||029 2073 6011|
|Private secretary firstname.lastname@example.org|
Royal College of Physicians (RCP)
British Cardiovascular Society (BCS)
Welsh Cardiovascular Society (WCVS)
European Society of Cardiology (ESC)
Heart Failure Association of the ESC (HFA)
Association of Inherited Cardiac Conditions (AICC)
Consultant cardiologist: University Hospital of Wales & University Hospital Llandough.
Senior Research Fellow (honorary): Cardiff University.
Reader (honorary): Cardiff Metropolitan University.
Cardiologist (honorary): Cardiff City Football Club.Back to top
In my spare time I have recently completed a major renovation of a Victorian property and am involved in several charities. I chair the Heart Research, Wales charity which aims to promote education and research in Wales and annually undertakes missions to Africa to help develop heart failure and pacing facilities in poorer countries (Pace4Life charity). I am a devoted father to my two children, and sadly, sporting activities these days are restricted to spectatorship and serving as a cardiologist for local football and rugby clubs.Back to top
Holds less than 0.1% of the shares in Spire Healthcare Group PLC.Back to top